Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology. Patients present loss of lung function, dyspnea and dry cough. Diagnosis requires compatible radiologic imaging and, in undetermined cases, invasive procedures such as bronchoscopy and surgical lung biopsy....

Descripción completa

Detalles Bibliográficos
Autores principales: Rindlisbacher, Barbara, Schmid, Cornelia, Geiser, Thomas, Bovet, Cédric, Funke-Chambour, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764001/
https://www.ncbi.nlm.nih.gov/pubmed/29321022
http://dx.doi.org/10.1186/s12931-018-0714-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764001/
https://www.ncbi.nlm.nih.gov/pubmed/29321022
http://dx.doi.org/10.1186/s12931-018-0714-2

Ejemplares similares